Clinical Trial Update: Intravitreal Aflibercept Injection or Early Vitrectomy for Diabetic Vitreous Hemorrhage [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing intravitreal aflibercept vs. early vitrectomy for diabetic vitreous hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Vitreous Hemorrhage

Drugs mentioned

• intravitreal aflibercept (aflibercept)

Snippet

Sponsor: Al Hadi Hospital | Conditions: Diabetic Vitreous Hemorrhage | Phase 4 | Status: COMPLETED